U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 21-27, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 21-27, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 04/27/2019
Location: Washington, DC
Subject: The National Foundation for Cancer Research: 2019 Szent-Györgyi Prize for Progress in Cancer Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and several members from the National Foundation for Cancer Research

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 04/24/2019
Location: Silver Spring, MD
Subject: Federal Partners Meeting: Exploring Common Data Models for Real World Evidence Development and Use
FDA Participant/Group: PETER STEIN; PETER MARKS; DAVID MARTIN; KIA COPELAND; JANET MAYNARD; CELIA SILVERMAN; JESSICA BERRELLEZ; SEAN KHOZIN; JACQUELINE CORRIGAN CURAY; PAUL HOWARD; STEFANIE KRAUS;
Non FDA Participant/Group: Gil Alterovitz (U.S. Department of Veterans Affairs); Donald Rucker, Jon White (The Office of the National Coordinator for Health Information Technology); Anand Shah, Mark Roche (U.S. Centers for Medicare & Medicaid Services); Anne Lubenow, Douglas Lowy, James Doroshow, William Dahut (National Institutes of Health);

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Polcy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/22/2019
Location: Silver Spring, MD
Subject: MasterCard Labs: Food Traceability
FDA Participant/Group: NINA ZIMDAHL; LARRY MORRIS;
Non FDA Participant/Group: Carmen Santoni, Deborah Barta, Leandro Nunes (MasterCard Labs);

Event Date: 04/23/2019
Location: Geneva, Switzerland
Subject: International Forum Food Safety and Trade
FDA Participant/Group: ERIC STEVENS; CAMILLE BREWER;
Non FDA Participant/Group: Several participants from the International Food Safety and Trade Forum

Event Date: 04/26/2019
Location: Silver Spring, MD
Subject: GS1 US Meeting: Food Traceability
FDA Participant/Group: Several members of the Food and Drug Administration
Non FDA Participant/Group: Angela Fernandez, Elizabeth Sertl (GS1 US);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/23/2019
Location: San Francisco, CA
Subject: Stanford Drug Discovery Symposium: Advancing the Development of Advanced Therapy Medicinal Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 04/24/2019
Location: Washington, DC
Subject: The National Academies of Sciences, Engineering, and Medicine Workshop: Regulatory Pathway: Development of Gene Therapies for Neurologic Disorders
FDA Participant/Group: N/A
Non FDA Participant/Group: Several stakeholders from academia, government, industry, and non-profit organizations

Event Date: 04/25/2019
Location: Boston, MA
Subject: Massachusetts Biotechnology Council Meeting: Accelerating the Development of Gene Therapies with a Focus on Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/23/2019
Location: Arlington, VA
Subject: Medical Device Innovation (MDIC) Consortium: Strategic Planning Session
FDA Participant/Group: ROCHELLE FINK; ANINDITA SAHA; KATHRYN O CALLAGHAN; MICHELLE TARVER; OWEN FARIS;
Non FDA Participant/Group: N/A

Event Date: 04/26/2019
Location: Arlington, VA
Subject: Medical Device Servicing Collaborative Community Kick-off Meeting
FDA Participant/Group: WILLIAM MAISEL; KATELYN BITTLEMAN; JOSHUA SILVERSTEIN;
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event